1. Rats fed on a protein-depleted diet for 8 weeks were repleted for 5 weeks on high-protein (HP), highprotein+20 g DL-carnitine/kg (HP+C), or low-protein+20 g DL-carnitine/kg (LP+C) diets. At 4 and 8 weeks of depletion, and 1 and 5 weeks of repletion, rats from each treatment group were given a benzoic acid tolerance test (BATT) or a cinnamic acid tolerance test (CATT) as a measure of liver function.
Fatty infiltration of the liver has long been recognized as a hallmark of kwashiorkor (Williams, 1935) . Although not always fatal, severe fatty liver correlates with a high mortality rate in children with protein-energy malnutrition (PEM) (Waterlow et al. 1960 ; McLean, 1962; Garrow & Pyke, 1967) . The cause of fatty liver of PEM is poorly understood, and specific treatment to increase the rate of removal of this fat during recovery has not been developed (Waterlow, 1975) .
Impaired lipid oxidation due to carnitine deficiency may play a role in fatty liver. A derivative of the amino acids lysine and methionine, carnitine is needed for normal oxidation of fatty acids in mitochondria, and may become deficient with diets that produce PEM. Carnitine supplementation may be a useful adjunct to the usual treatment for PEM, both to correct carnitine deficiencies (Broquist & Borum, 1981) and to serve as a pharmacological aid to hasten fat removal (Sengers et al. 1980) . Research efforts to demonstrate effective treatments for fatty liver, however, are hampered by the absence of liver function tests appropriate for children with PEM.
The present study evaluates two liver function tests (the benzoic acid tolerance test (BATT) and the cinnamic acid tolerance test (CATT)) in weanling rats at different stages of protein depletion and repletion, and assesses the impact of carnitine supplementation on recovery from fatty liver in experimental PEM.
M E T H O D S
Male weanling Sprague-Dawley rats were fed on stock diet until they attained a weight of 100-13Og at the initiation of the study. They were housed individually in suspended stainless-steel mesh cages in a temperature-controlled environment with 12 h light-12 h dark cycles. The study was designed in two stages, a depletion stage (8 weeks) and a repletion stage (5 weeks). For the depletion stage, rats were randomly assigned to either a protein-depleted diet (5 g lactalbumin/kg) or a control diet (a stock open-formula cereal-based diet). The protein-depleted diet (Table 1) has been shown to produce symptoms of kwashiorkor, including oedema, in rats within 2 months (Edozien, 1968; Anthony & Edozien, 1975) .
Protein-depleted rats were repleted on one of three diets : 180 g lactalbumin/kg (highprotein; HP) diet; 180 g lactalbumin plus 20 g DL-carnitine/kg (HP+C) diet; or 5 g lactalbumin/kg (low-protein) plus 20 g m-carnitine (LP + C) diet. Control rats continued on a stock diet during the repletion stage. This diet was provided in pelleted form and had the following composition (g/kg diet): maize 525, wheat 112, soya bean 200, lucerne (Medicago saliva) De-Hi 50, brewer's yeast 50, dehydrated whey 25, dicalcium phosphate 25, limestone 5, iodized sodium chloride 5, trace mineral mix with cobalt 1, poultry developer vitamin premix 2.5.
At four time-periods in the study (4 weeks and 8 weeks of the depletion stage, and 1 week and 5 weeks of the repletion stage) rats from each group were randomly chosen for liver function tests using either BATT or CATT. These tests measure the molar percentage of a benzoic acid or cinnamic acid dose excreted as hippuric acid in 24 h. A total of 137 rats were given tolerance tests, with a minimum of five rats from each treatment group given each test. Test substances were administered intraperitoneally in a 0.2 M-neutral saline solution (9 g sodium chloride/l) containing a molar equivalent of glycine at a volume calculated to deliver 1 mmol test substance/kg body-weight. Urine was collected for 24 h and freezedried. At the time of analysis, urine samples were reconstituted to a volume estimated to contain approximately 1 mg hippuric acid/ml. Hippuric acid in duplicate urine samples was determined by thin-layer chromatography .
Liver function tests in PEM
Immediately following the tolerance tests, rats were killed by asphyxiation with carbon dioxide. Plasma samples and weighed livers were frozen for subsequent analysis. Liver lipid was determined gravimetrically (Harding et al. 1967) , liver total carnitine according to Pace et al. (1978) , and plasma total carnitine according to McGarry & Foster (1976) in at least five rats from each treatment group. Both carnitine assays are specific for the L-carnitine isomer.
One-way analysis of variance was used to analyse response variables by treatment group. Log transformations were computed for values for liver lipid and liver carnitine concentration before statistical analysis. Where significant differences were found, means were compared using Student-Newman-Keul's multiple-comparisons test. Correlation coefficients between liver function tests and lipid variables were also determined (Steel & Torrie, 1975) .
RESULTS

Body-weight and food intake
Body-weight fell markedly for rats fed on a low-protein diet during the 8-week depletion period. Total loss averaged 45 (SE 12) g. Almost 60% of the loss occurred in the first 2 weeks on the depletion diet. Control rats gained an average of 250 (SE 70) g during the same period. Weights of protein-depleted rats rose when adequate dietary protein was reintroduced during the repletion period. Repletion weight gain for the group fed on diet HP+C, however, was significantly less (P < 0.025) than for the group fed on the HP repletion diet. Overall, average weight gain was approximately 13 g less in the former group over the 5-week period.
When carnitine alone was added, in the LP+ C repletion diet, protein-depleted rats continued the decline in weight established during the depletion stage. Food intake averaged 5 (SE 1) g/d over the course of the 5-week repletion period, so that total DLcarnitine intake for 35 d was 21 mmol. Because of their greater mean daily food intake (1 1 (SE 1.5) g/d) rats depleted on diet H P + C consumed over twice as much supplemental carnitine during the repletion period, an average of 48 mmol.
Liver and plasma carnitine
Protein-deficient rats developed a slight but non-significant deficit in liver carnitine concentration relative to controls (Table 2) , and repletion with the HP diet was associated with a significant deficit in liver carnitine concentration (Table 3) . Even after 5 weeks of repletion, rats treated with adequate protein were unable to recover control concentrations of liver carnitine. Growth of the liver, however, meant that these rats were able to increase the amount of carnitine per liver from 867 (SE 152) nmol/liver at the end of the depletion period to 2075 (SE 253) nmol/liver 1 week after beginning the repletion diet (values not shown).
Rats fed on the HP + C repletion diet, on the other hand, showed a marked increase in liver carnitine concentration by 1 week repletion, and this value remained as high as control values after 5 weeks of HP + C feeding (Table 3) . For rats fed on the LP + C repletion diet, liver carnitine concentration was higher than that of controls after 5 weeks of carnitine supplementation.
Protein-depleted rats developed a significant deficit in plasma carnitine relative to controls, and this level remained low on the HP repletion diet. In both carnitinesupplemented groups, HP + C and LP + C, plasma carnitine rose dramatically after 1 week of supplementation, but fell after 5 weeks of supplementation. For the HP + C group, 5 weeks of supplemental carnitine was associated with plasma carnitine levels higher than those of HP-repleted rats and equivalent to controls. While plasma carnitine concentration showed a significant positive correlation (r 065, P < 0 0 5 ) with liver weight, liver carnitine concentration showed a non-significant negative correlation (r-0-1 1) with liver weight.
Liver lipid Protein-depleted rats had high liver lipid concentrations, extending from a minimum (74 mg/g wet weight) within the range of control rats to a maximum (200 mg/g wet weight)
nearly three times the control mean. Rats repleted with diets HP or HP + C showed a rapid reduction in liver lipid concentration to levels equivalent to those of controls. Rats fed on the LP+C repletion diet also showed a decline in lipid concentration after 1 week of supplemental carnitine, but liver lipid concentration rose after 5 weeks on the diet. Liver weights increased with protein refeeding, but did not equal control levels after 5 weeks of refeeding (Table 3) .
Tolerance tests Both BATT and CATT were severely depressed in protein-depleted rats (Tables A and 5). BATT, for example, was close to 90 YO in control rats throughout the study. For proteindepleted rats, BATT averaged only about two-thirds that amount during the depletion period ( Table 4 ) and this value continued to decline during repletion in the LP + C group (Table 5) .
Control animals in all four test-periods tolerated a cinnamic acid load essentially as well as a benzoic acid load. Generally, however, most treatment groups were slightly, though not significantly, better able to metabolize and excrete benzoic acid, with a somewhat lower percentage of a cinnamic acid test dose appearing in the urine as hippuric acid in 24 h. Protein-depleted rats supplemented with carnitine but no added protein during the repletion period showed a reversal of the general relation between CATT and BATT; these rats showed slightly greater tolerance to cinnamic acid than to benzoic acid at both 1 week and 5 weeks repletion (Table 5) .
After just 1 week of repletion, HP-and HP + C-fed rats performed both tolerance tests as efficiently as controls, and they maintained this level of efficiency for the remainder of the repletion period. The apparent rapid recovery in liver function by 1 week of protein repletion may be associated with a lesser challenge to the liver in these rats. Because of the rapid growth of the liver relative to body-weight, the effective dose of test substances was only 16 (SE 0.4) pmollg liver in the HP group and 17 (SE 0.8) pmollg liver in the HP + C group at 1 week repletion, but ranged from 24 to 30 (SE 0&1*1) pmollg liver in all other groups. CATT also rose substantially with protein refeeding, but was significantly less than controls after 1 week of repletion in HP + C-fed rats. By 5 weeks of repletion CATT had returned to control levels in both HP-and HP + C-fed rats.
The highest positive correlation coefficients were found between liver weight and CATT or BATT (Table 6 ) utilizing all data-points. However, when correlations were examined by group for CATT v. liver weight, five groups showed statistically non-significant negative correlations. While there was no pattern to the positive or negative r values explainable by the length of time or type of diet fed, this phenomenon suggests some caution in interpretation of the overall strongly positive correlation found between CATT and liver weight. The small number of animals in each group precluded further analysis of the anomaly.
Liver lipid concentration was negatively related to CATT (r -0.62) ( Table 6 ). Using multiple-regression analysis (not shown) the R2 for CATT, including the liver weight variable, was 0.63, and for liver weight + liver lipid concentrations was 0.65. Additional variables did not further explain the variation in CATT. 
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CATT (molar percent) t CATT and BATT were tested on different animals within a group, thus no coefficients can be determined.
DISCUSS I 0 N
Liver function tests
The cause and treatment of the fatty liver of PEM are poorly understood. Usual treatment protocols may actually increase liver lipid (McLaren et al. 1968) . Decreased lipoprotein synthesis for lipid mobilization or increased hepatic triglyceride synthesis probably contribute to the fatty liver of PEM (Truswell, 1975; Portman et al. 1981) , but limited oxidation of liver lipid due to carnitine deficiency may also play a part.
Deficiency of carnitine lowers the activity of carnitine acyltransferase, an enzyme essential for fatty acid oxidation in mitochondria, resulting in accumulation of lipid within cells (McGarry & Foster, 1980) . Carnitine is ordinarily biosynthesized from lysine and methionine, but the inadequate diets that produce kwashiorkor are likely to be limited both in the amino acid precursors for carnitine (Broquist & Borum, 1981) and in preformed carnitine itself (Mitchell, 1978) . Low plasma carnitine levels have been observed in children and adults on protein-deficient diets (Khan & Bamji, 1977; Tanphaichitr et al. 1980) . Clinical research efforts to improve understanding of the liver pathology of PEM are hampered by the absence of liver function tests appropriate for children with PEM. Many of the standard liver function tests distinguish only advanced stages of liver damage, including necrosis and cirrhosis, not normally seen with PEM (Srikantia et al. 1964; Tobiasson & Boeryd, 1980) . Other liver function tests assess blood flow through the liver, or patency of the biliary tree rather than impaired parenchymal cell function (Royle et al. 1978; Gitnick, 1981) . Alternative tests for assessing liver function (for example, serum transport protein measurements) reflect an acute response to protein deprivation rather than functional impairment associated with parenchymal cell damage (Golden, 1982) . These tests are particularly inappropriate for children with PEM.
Alternative proposals to measure liver function in PEM need to be evaluated. Use of indocyanin green uptake to assess liver impairment in protein-deprived rats was reported to be specific and sensitive (Jahoor & Jackson, 1982) . A similar effort was made in the present study to assess BATT and CATT for correlation with liver lipid concentration and with liver weight in rats at different stages of protein depletion and repletion.
Benzoic acid is detoxified in the liver by conjugation with glycine to form hippuric acid. This two-stage biochemical process takes place on the inner membrane of the coenzyme A (catalysed by butyrate-CoA ligase (benzoyl CoA synthetase; EC 6 . 2 . I .2)) and a conjugation step whereby the benzoyl CoA is transferred to glycine to form hippurate catalysed by glycine acyltransferase (EC 2 . 3 . 1 .13). Hippuric acid is then eliminated by the kidney (Schnacter & Taggart, 1954; Gatley & Sherratt, 1977) .
In the 1930s, Quick (1933) noted that this synthesis is dependent on two functions of the healthy liver: its ability to conjugate benzoic acid with glycine and its ability to furnish glycine, a non-essential amino acid. Quick (1933) determined that, on exposure to oral benzoic acid, patients with several types of liver disease excreted reduced amounts of hippuric acid compared with normal controls, and proposed a test for liver function using this determination.
The original method used a gravimetric analysis for determining hippuric acid in urine. This problematical analysis hampered routine use of Quick's (1933) test for liver function. A faster and more sensitive thin-layer chromatography method can now replace the gravimetric analysis Benzoic acid appears to be safely used to test liver function. It is present naturally in foods, especially berries and fruit, and is approved by the Food and Drug Administration in the United States for use as a preservative by the food industry. In the present study, control rats excreted high percentages of the benzoic acid dose within 24 h following its administration. Protein-deficient rats excreted much lower percentages. The assumptions made for the standard reading of the test results attribute this to poor conjugating ability of the liver parenchymal cells, since adequate glycine was supplied with the benzoic acid dose. It should be noted that the test was not specific for fatty liver: BATT correlated as well with liver weight as with liver lipid concentration.
CATT is similar in principle to BATT. The normal liver, through /3-oxidation, converts cinnamic acid to benzoic acid, which is then handled just as exogenous benzoic acid is handled: it is conjugated with glycine for excretion as hippuric acid (Fig. 1) . Again, abnormal hepatic function is reflected in decreased excretion of hippuric acid. Unlike BATT, this test has not yet been used clinically, but has been suggested as a liver function test based on its direct relation with liver lipid inetabolism (Zimmerman, 1974) .
Both the present study and previous work with healthy rats has shown that cinnamic acid is essentially as good a precursor for urinary hippuric acid as benzoic acid, with /3-oxidation of cinnamic acid occurring efficiently in normal hepatocytes (Teuchy & Van Sumere, 1971) .
Several problems might be anticipated with use of BATT and CATT in detecting compromised liver function in PEM : the first is malnutrition-induced intestinal malabsorption of an orally administered dose. Varying degrees of malabsorption could make the tests difficult to standardize from one patient to another. The present study used intraperitoneal delivery of cinnamic acid and benzoic acid. Route of administration of test substances to human beings where malabsorption may exist needs to be determined experimentally. A second anticipated problem is that altered nitrogen economy might change the availability of glycine for the conjugation process (Beliveau & Brusilow, 1987) . In the present study, glycine was provided with the test substances in equimolar amounts in order to eliminate this complication. Excess glycine appears to be readily catabolized in rat liver (Petzke et al. 1986 ). DeVries & Alexander (1948) described such a modification of Quick's (1933) original test in an attempt to focus on the liver's conjugating ability rather than its amino acid synthesizing ability. A final caution in interpretation of these liver function tests in PEM is that blood flow through the liver and kidney may be abnormal, and thus alter hepatic uptake of the test compound or excretion of hippuric acid. Although impaired blood flow owing to cirrhosis is not a problem in the liver disease of PEM, cardiac output is often reduced, lowering flow-rate through both the liver and the renal glomeruli (Royle et al. 1978) . These considerations were not addressed by Quick (1933) in his original papers on use of this liver function test, but should not be ignored in attempts to explain the differences among experimental groups in the present study. Depressed cardiac output or glomerular filtration rate, rather than hepatic cell disruption, may be responsible for at least part of the depressed hippuric acid excretion observed in this rat model of protein deficiency.
Effect of carnitine supplementation
While carnitine deficiency has not been reported in normal human beings on adequate diets, low plasma carnitine levels are observed in several pathological conditions, including PEM (Khan & Bamji, 1977; Tanphaichitr et al. 1980) . Previous work in rats has shown protein deficiency to be associated with a tissue redistribution of carnitine: liver levels rise as plasma levels fall (Khan & Bamji, 1979) . It is unclear whether the inverse relation between liver and plasma carnitine concentrations is an adaptive response to the proteindeficient status of the animals or is a maladaptive inability to maintain homeostatic conditions in the absence of adequate protein nutrition.
In the present study, plasma carnitine fell during protein depletion to levels below the control levels, while liver carnitine concentration remained as high as control levels. While plasma carnitine concentration showed a significant positive correlation with liver weight, liver carnitine concentration showed a slight, though non-significant, negative correlation with liver weight, indicating that liver carnitine concentration tended to rise slightly with declining protein status. This raises the possibility that contraction in liver size rather than redistribution of carnitine could explain the retention of liver carnitine concentration in the face of reduced plasma carnitine in protein-depleted rats. Protein-depleted rats fed on diet HP (a high-protein diet without supplemental carnitine) showed a continued decline in liver carnitine concentration during repletion, although carnitine levels per total liver rose substantially with growth of the liver. Thus, while these animals were apparently capable of biosynthesizing carnitine, they were unable to return liver carnitine concentration to control levels even after 5 weeks of protein repletion.
Liver carnitine concentration did, however, reach control levels when carnitine was added to a high-protein repletion diet. Protein alone may not have been sufficient to allow liver carnitine synthesis to proceed at rates adequate to restore fully liver carnitine concentration. Liver carnitine concentration was substantially higher at 1 week repletion than at 5 weeks repletion, however, in carnitine-supplemented rats.
This fall in liver carnitine concentration over time with continued carnitine supplementation may be associated with feeding supplemental DL-carnitine rather than the Lisomer. D-cartinine has been shown to displace t-carnitine in rat heart and skeletal muscle (though not in liver) (Paulson & Shug, 1981; Rebouche, 1983) . A racemic mixture, however, did raise tissue L-carnitine above control levels (Rebouche, 1983) , and whether Dcarnitine contributed to the decline in liver L-carnitine observed after 5 weeks of DLcarnitine feeding in the present study is unclear.
Rats fed on LP+C (a low-protein repletion diet supplemented with carnitine) accumulated liver carnitine more slowly than carnitine-supplemented protein-repleted rats, and reached a higher concentration by 5 weeks than at 1 week repletion. Assimilation of carnitine into the livers of protein-deprived animals appears to be poor; both intestinal absorption and uptake from blood to hepatocyte may be depressed, since cellular membrane transport of carnitine is a protein-dependent process (York et al. 1983) .
Although carnitine has been shown to reduce lipid infiltration in certain pathological conditions (Sengers et al. 1980) , carnitine alone did not significantly enhance liver recovery from fat infiltration in protein-depleted rats. Although it did promote a modest temporary decline, liver lipid concentration remained well above control levels at the end of the study (Table 3) . Liver function as measured by BATT and CATT did not improve but continued to decline in the LP+C group, probably because the rats were exposed to an additional period of protein deprivation.
Additional protein, however, was associated with a rapid reduction in the high lipid concentration induced by the protein-deficient diet. Liver fat concentration returned to control levels within 1 week of initiating the high-protein repletion diet. No advantage in reducing liver lipid concentration was observed when carnitine was added to the protein supplement. Carnitine plus protein induced a transient diarrhoea which may have accounted for the modestly delayed recovery of the liver on this regimen. The diarrhoea had resolved after 2 weeks.
The effects of treatments on removing fat v. lowering fat concentration in liver cells due to growth of the liver are difficult to separate in the present study. The rapid expansion of liver size when protein was re-introduced could explain the entire reduction in liver lipid concentration to control levels. Mean increase in liver weight was 226 YO after 1 week on a high-protein diet, while the mean decrease in liver lipid concentration was only 29 YO.
Only a modest increase in liver weight, however, was observed when carnitine alone was added to the depletion diet, yet lipid concentration fell temporarily to a level equivalent to controls. This reduction may be an effect of supplemental carnitine on lipid oxidation.
The rat model for PEM used in the present study provided only specific, limited information on the effects of carnitine supplementation on fatty liver and on the sensitivity and specificity of the tolerance tests for liver function. Much further work remains in evaluating these aspects in human subjects.
